Traders should be highly cautious. The stock is in a Nasdaq delisting process, which can lead to a 'penny stock' status, severely limiting liquidity. The ATM program allows the company to sell shares at will, creating constant downward pressure on the price. Any capital raise will be highly dilutive given the low share price. Monitor the outcome of the Nasdaq hearing, as a delisting would be a major negative catalyst.
Price Chart
Executive Summary
Ernexa Therapeutics has filed an S-3/A shelf registration, authorizing up to $50 million in securities offerings, including a specific $9.25 million ATM program with Brookline Capital Markets. The company, which recently raised $9.5 million in a February 2026 public offering, is using this shelf to raise additional capital. However, it faces a significant risk of delisting from Nasdaq due to its stock price falling below $1.00 for 30 consecutive days, and it has already been denied a standard 180-day compliance period because of a recent reverse stock split.
Key Financial Metrics
Key Facts
- Filed an S-3/A shelf registration for up to $50 million in securities, including a $9.25 million ATM program.
- Stock price is $0.2657, well below Nasdaq's $1.00 minimum bid price requirement, triggering a delisting notice.
- Denied a standard 180-day compliance period for the bid price rule due to a recent reverse stock split.
- Plans to request a hearing with the Nasdaq Hearing Panel to appeal the delisting.
- Recent February 2026 offering raised $9.5 million in net proceeds, temporarily boosting stockholders' equity above $2.5 million.
- Company is preclinical-stage with no revenue, and its auditor's report cites substantial doubt about its ability to continue as a going concern.
Financial Impact
The $9.25 million ATM offering could result in significant dilution. At the current share price of $0.2657, selling the full amount would issue approximately 34.8 million new shares, more than doubling the current outstanding shares of 29.15 million.
Risk Factors
- High risk of delisting from Nasdaq, which would severely impact liquidity and investor confidence.
- Significant and immediate dilution from the ATM program, as the company can sell shares at the current low price.
- The company has a history of financial distress, including a reverse stock split and recurring losses, raising going concern issues.
- The stock is highly volatile and speculative, with a market cap of only $1 million.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3/A Filing (Primary) | 0001493152-26-012387 |
| Exhibit: ex23-1.htm | 0001493152-26-012387 |
| Exhibit: ex23-2.htm | 0001493152-26-012387 |
| Document: 0001493152-26-012387-index-headers.html | 0001493152-26-012387 |
| Document: 0001493152-26-012387-index.html | 0001493152-26-012387 |
| Document: 0001493152-26-012387.txt | 0001493152-26-012387 |
| CONTEXT: 10-Q (2025-11-07) | 0001493152-25-021287 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | Press Release | $2.08 | awaiting T+5 | — | $1.94 (−6.60%) |
Oct 15, 2026 10d ago | 8-K | $2.09 $2.07 | ▼ −1.20% | ▼ −0.77% | $1.94 (−7.27%) |
Oct 1, 2026 25d ago | Press Release | $2.96 $2.49 | ▼ −15.88% | ▼ −17.18% | $1.94 (−34.53%) |
Sep 30, 2026 26d ago | Press Release | $3.20 $2.39 | ▼ −25.31% | ▼ −27.23% | $1.94 (−39.44%) |
Sep 16, 2026 5w ago | 8-K | $3.76 $3.62 | ▼ −3.72% | ▼ −4.32% | $1.94 (−48.46%) |
Sep 16, 2026 5w ago | 8-K | $3.76 $3.62 | ▼ −3.72% | ▼ −4.32% | $1.94 (−48.46%) |
Jul 14, 2026 14w ago | Press Release | $6.06 $5.43 | ▼ −10.40% | ▼ −9.10% | $1.94 (−68.02%) |
Jun 26, 2026 17w ago | 8-K | $7.03 $6.44 | ▼ −8.39% | ▼ −9.78% | $1.94 (−72.43%) |
Jun 17, 2026 18w ago | Press Release | $5.89 $6.30 | ▲ +6.96% | ▲ +8.00% | $1.94 (−67.10%) |
May 27, 2026 21w ago | Press Release | $11.14 $8.00 | ▼ −28.19% | ▼ −29.39% | $1.94 (−82.60%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers